Edwards Lifesciences Valve

Edwards Lifesciences, Wolfe

Edwards Lifesciences downgraded at Wolfe on TAVR worries

Edwards Lifesciences (NYSE:EW) traded lower in the premarket on Thursday after Wolfe Research downgraded the heart device maker, citing concerns over its prospects in the market for Transcatheter Aortic Valve Replacement (TAVR).

Business Insider · 1d

Edwards Lifesciences downgraded to Underperform at Wolfe Research

Wolfe Research downgraded Edwards Lifesciences (EW) to Underperform from Peer Perform with a $60 price target The firm says its core

Insider Monkey on MSN · 1d

Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)?

Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, Wedgewood Composite’s net return was 5.

Hosted on MSN · 23h

Edwards Lifesciences exec sells $343,735 in stock

Following these transactions, Bobo holds 46,935.7184 shares directly, with additional holdings in indirect accounts, including 38,616.6145 shares in a 401(k) and 135,152 shares held by a trust. The company maintains robust financial health with a current ratio of 3.

Business Insider · 2d

Bernstein Reaffirms Their Hold Rating on Edwards Lifesciences (EW)

In a report released yesterday, Lee Hambright from Bernstein maintained a Hold rating on Edwards Lifesciences (EW – Research Report). The

Forbes1d

Edwards Lifesciences

Edwards Lifesciences Corp. engages in the patient ... Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter ...

High Court Axes Edwards' Bid to Limit Drug-Patent Safe Harbor

The US Supreme Court rejected a case asking the justices to interpret a patent-infringement safe-harbor provision in a ...

IPWatchdog3d

Supreme Court Denies Petitions on Hatch-Waxman Safe Harbor, ITC Economic Prong Analysis and Stay of Federal Trade Secret Claims

On Monday, January 13, the U.S. Supreme Court issued an order list denying petitions for writ of certiorari in three cases ...

Equities Analysts Set Expectations for EW FY2024 Earnings

Zacks Research raised their FY2024 earnings per share (EPS) estimates for Edwards Lifesciences in a research note issued on ...

bovnews3d

Edwards Lifesciences Corp (EW) Stock Sees Market Value Hit $41.93 billion: What Are the Implications?

Edwards Lifesciences Corp (EW) stock saw a decline, ending the day at $71.09 which represents a decrease of $-2.33 or -3.17% from the prior close of $73.42. The stock opened at $70.54 and touched a ...

Medscape2d

The Relevance of Prosthesis-patient Mismatch After Aortic Valve Replacement

He has also acted as a Consultant for Sorin and received research support from Edwards Lifesciences. Jean G. Dumesnil received Speakers' Bureau honoraria from Medtronic and St Jude Medical.

Capital Investment Advisors LLC Sells 143 Shares of Edwards Lifesciences Co. (NYSE:EW)

Capital Investment Advisors LLC lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.4% during the fourth quarter, according to its most recent disclosure with the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results